1. Home
  2. PRME vs VLRS Comparison

PRME vs VLRS Comparison

Compare PRME & VLRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Prime Medicine Inc.

PRME

Prime Medicine Inc.

HOLD

Current Price

$3.43

Market Cap

536.4M

Sector

Health Care

ML Signal

HOLD

Logo Controladora Vuela Compania de Aviacion S.A.B. de C.V.

VLRS

Controladora Vuela Compania de Aviacion S.A.B. de C.V.

HOLD

Current Price

$9.39

Market Cap

923.4M

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRME
VLRS
Founded
2019
2005
Country
United States
Mexico
Employees
N/A
7098
Industry
Medicinal Chemicals and Botanical Products
Air Freight/Delivery Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
536.4M
923.4M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
PRME
VLRS
Price
$3.43
$9.39
Analyst Decision
Buy
Buy
Analyst Count
6
8
Target Price
$7.56
$9.16
AVG Volume (30 Days)
2.9M
600.4K
Earning Date
05-08-2026
04-27-2026
Dividend Yield
N/A
N/A
EPS Growth
18.18
N/A
EPS
N/A
N/A
Revenue
$4,632,000.00
N/A
Revenue This Year
$7.06
$13.96
Revenue Next Year
$47.01
$12.62
P/E Ratio
N/A
N/A
Revenue Growth
55.28
N/A
52 Week Low
$2.28
$4.40
52 Week High
$6.94
$10.80

Technical Indicators

Market Signals
Indicator
PRME
VLRS
Relative Strength Index (RSI) 53.56 70.77
Support Level $3.16 $8.59
Resistance Level $3.68 $9.81
Average True Range (ATR) 0.25 0.43
MACD 0.04 0.14
Stochastic Oscillator 65.56 84.72

Price Performance

Historical Comparison
PRME
VLRS

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Its program, PM577 for Wilson Disease, is designed to initially correct the H1069Q mutation in the ATP7B gene and is supported by preclinical data showing targeted correction and restoration of copper homeostasis in animal models. In addition, PM647 is being developed for alpha-1 antitrypsin deficiency, or AATD, another liver targeted disease with substantial unmet need.

About VLRS Controladora Vuela Compania de Aviacion S.A.B. de C.V.

Controladora Vuela Compania de Aviacion SAB de CV is a low-cost airline flying to Mexico, the United States, Central, and South America. It uses promotional fares to stimulate demand, and the base fares are priced to compete with long-distance bus fares in Mexico. Revenues from the air transportation of passengers are recognized earlier when the service is provided or when the non-refundable ticket expires on the date of the scheduled travel. Non-passenger revenues include revenues generated from other non-passenger services and cargo services. The Company has two geographic areas identified as domestic (Mexico) and international (United States of America, Central America, and South America).

Share on Social Networks: